We our domestic biotech clients Co. E and Co. I regarding a sublicensing company sublicense-in candidate substances from a technology startup company established by U.S. university professors, and conduct joint R&D throughout the pipeline. We helped navigate the potential conflicts of interest among the universities as technology rights holders, the technology startup companies as primary licensees, and our clients domestic as secondary licensees.
We create shared value and social change by using
our expertise and innovation to help our pioneering clients.